POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter
Tumblr Google+ Flickr
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » August 2010

What's That Mean?
(just double-click it!)

NEW! If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:


Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


email print

August 27, 2010

High Level of Bone Loss in Men Recently Infected With HIV

Levels of bone mineral loss were far higher in a small group of men who had been recently infected with HIV than is typically seen in HIV-negative men of similar age and demographics, according to a study published in the September 10 issue of AIDS.

Numerous studies have now confirmed that bone mineral loss—called osteopenia when the bone loss is moderate and osteoporosis when it is more severe—is far more common in people with HIV, particularly in HIV-positive men. These studies, however, have varied in their methods and in the specific populations they analyzed. For example, most studies have looked predominantly at HIV-positive men and women who had been infected for many years and have been receiving antiretroviral (ARV) therapy. Conversely, few studies have evaluated rates of bone mineral loss earlier in the course of HIV infection.

These factors have made it difficult to understand what, exactly, is driving the higher rates of osteopenia and osteoporosis among people living with HIV. High viral load, low CD4 count, smoking history, low body mass index and certain ARV drugs have all been associated with bone mineral loss, but no studies have been able to prove conclusively that any one of these factors causes the bone condition.

To shed more light on this subject, Marlous Grijsen, MD, from the University of Amsterdam, and her colleagues conducted bone scans on 33 very recently infected men, only one of whom was taking ARV therapy. Most of the men were white and had high CD4 cell counts. The average age was 38, just over half were smokers, and their body mass index—a calculation drawn from height and weight—was generally on the low side of normal. Thirty-two of the subjects were men who have sex with men (MSM).

Many were so recently infected that they didn’t yet test positive by a Western Blot antibody assay: their infections had to be confirmed by viral load. For those in whom infection could be confirmed by Western Blot, the average length of time since a positive test was 24 days.

Grisjen’s team found that bone mineral loss was far more common among the men in their study than what would be expected in HIV-negative men of a similar age. In fact, 45 percent had osteopenia, and 6 percent had osteoporosis. The three factors associated with lower bone density were older age, low BMI and higher levels of thyroid-stimulation hormone.

The reasons for these unusually high rates of bone mineral loss are unclear. There is some evidence, according to Grisjen and her colleagues, that viral replication might have contributed to bone mineral loss. It could also be that other factors—such as recreational drug use—were to blame. Previous studies have found that methamphetamines, nitrous oxide (poppers) and cigarette smoking contribute to reduced bone density. The authors did not have sufficient data to make these kinds of analyses, however.

“This study shows a high rate of osteopenia and osteoporosis early in the course of HIV infection, before the possible influence of [ARVs],” the authors concluded. “Longitudinal studies are needed to evaluate changes over time. Studies involving HIV-negative controls will be a key in understanding whether these findings relate to the presence of HIV or other risk factors affecting bone health among MSM.”

Search: Bone mineral, bone mineral density, osteopenia, osteoporosis, recent infection, Western Blot, MSM, BMI


Scroll down to comment on this story.

email print

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

  comments 1 - 1 (of 1 total)    

polypagan, Berea, KY, 2010-09-02 15:08:00
This is fascinating! I also showed moderate boneloss early in the course of the disease. I had already started on ARV's, so it was impossible to tell if it was due to the virus or medications. I look forward to more information on this topic.

comments 1 - 1 (of 1 total)    


[Go to top]


Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV 101
HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
Disclosing Your Status
POZ TV
Read the Blogs
Visit the Forums
Women
African American
Latino
Community
Advocacy
Job Listings
Events Calendar
Starting Treatment
My Cool Tools


    janiceprice85
    Valdosta
    Georgia


    olliecando
    West Hollywood
    California


    burrola
    Upland
    California


    mtaylor1973
    Johnson City
    Tennessee
Click here to join POZ Personals!
Talk to Us
Poll
Have you disclosed your HIV-positive status at work?
Yes
No

Survey
What Would You Do to End AIDS?

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.